ANU: Plant SynBio Foundry – Advanced capability in plant synthetic biology and biomanufacturing
Opportunity for
- Researchers and startups in need of advanced plant synthetic biology and breeding infrastructure and capabilities
- Industry partners seeking gene editing, trait development, or biomanufacturing support
- Innovators working on plant-based solutions for ag, food, or health sectors
- Investors and collaborators supporting commercialisation of agbiotech innovation
Opportunity description
Industry challenge
Commercialising plant synthetic biology remains challenging and resource-intensive, with innovators often constrained by limited access to automated platforms, advanced breeding tools, and regulatory expertise to move ideas from lab to field. Without these capabilities, many promising plant technologies stall before reaching commercial application or are forced offshore for development, increasing cost and risk.
The Plant SynBio Foundry, supported by BioPlatforms Australia, addresses this gap by providing a coordinated national capability to accelerate plant synthetic biology innovation. The Canberra node, hosted at the Australian National University (ANU), delivers specialised infrastructure and expertise to support trait discovery, metabolic pathway optimisation, and plant biomanufacturing.
Current opportunity
The ANU node of the Plant SynBio Foundry is open to expressions of interest from researchers, startups, and industry seeking access to cutting-edge facilities and expertise in plant synthetic biology.
Capabilities include:
- Accelerated plant breeding through genome editing, genetic engineering, and trait development across cereals, oilseeds, fruits, and vegetables
- Automated innovation platform for high-throughput discovery and validation of metabolic pathways and enzyme optimisation
- R&D consulting and collaboration services, including strategic project advice, data analytics, and workforce training
- SynBio incubation, providing infrastructure, mentorship, and technical support for startups, plus regulatory and IP advisory services
Researchers and companies may also be eligible for BioPlatforms Australia voucher schemes to offset access costs.
This is a unique opportunity to engage with a nationally funded synthetic biology capability designed to help innovators advance from concept to commercialisation.
Opportunity background
Funded through BioPlatforms Australia under the National Collaborative Research Infrastructure Strategy (NCRIS), the Plant SynBio Foundry operates across four leading university nodes: the University of Adelaide, ANU, La Trobe University, and University of Western Australia.
Together, the network supports Australia’s bioeconomy by linking researchers and industry with open-access infrastructure, regulatory guidance, and commercialisation pathways that accelerate translation of plant innovations from lab to market.